Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of transfusion-dependent β-thalassemia (TDT): Expert insights and practical overview from the Middle East
Amal El‐Beshlawy, Hany Dewedar, Salwa Hindawi, et al.
Blood Reviews (2023), pp. 101138-101138
Open Access | Times Cited: 12

Showing 12 citing articles:

Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trial
Maria Domenica Cappellini, Vip Viprakasit, Pencho Georgiev, et al.
The Lancet Haematology (2025)
Closed Access | Times Cited: 1
State of the art CRISPR-based strategies for cancer diagnostics and treatment
Emma Di Carlo, Carlo Sorrentino
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Real Life Blood Management Practices in Thalassemia and Myelodysplastic Syndrome Patients
Mürüvvet Seda Aydın, Esra Cengiz
Anemia (2025) Vol. 2025, Iss. 1
Open Access
Long-term Clinical Efficacy and Safety of Thalidomide in Patients with Transfusion‑dependent β‑thalassemia Major
Md. Abdul Halim Shah, Muhammad Basit Khawaj, M Aktar Ali, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 1, pp. 784-791
Closed Access
What we now BELIEVE is achievable with luspatercept in transfusion-dependent β-thalassaemia
Khaled M. Musallam
The Lancet Haematology (2025)
Closed Access
Constructing a novel clinical indicator model to predict the occurrence of thalassemia in pregnancy through machine learning algorithm
Yongzhu Long, Wenxue Bai
Frontiers in Hematology (2024) Vol. 3
Open Access | Times Cited: 2
Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?
Gian Luca Forni, Antonis Kattamis, Kevin H.M. Kuo, et al.
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 8
Closed Access | Times Cited: 2
Exploring experiences of mothers of children with thalassemia major in Indonesia: A descriptive phenomenological study
Nelly Hermala Dewi, Setyowati Setyowati, Enie Novieastari, et al.
Belitung Nursing Journal (2024) Vol. 10, Iss. 5, pp. 585-592
Closed Access | Times Cited: 1
Impact of Empagliflozin on the Outcomes of β-Thalassemia Major in Patients With Type 2 Diabetes Mellitus: The THALEMPA Observational Study
Anas Ibraheem, Waseem F. Al Tameemi
Cureus (2024)
Open Access
Renal Findings in Patients with Thalassemia at Abdominal Ultrasound: Should We Still Talk about “Incidentalomas”? Results of a Long-Term Follow-Up
Carmina Fatigati, Antonella Meloni, Silvia Costantini, et al.
Diagnostics (2024) Vol. 14, Iss. 18, pp. 2047-2047
Open Access
Beta Thalassemia in Children: Established Approaches, Old Issues, New Non-Curative Therapies, and Perspectives on Healing
Raffaella Origa, Lamya Abd Alkarem Issa
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6966-6966
Open Access
Luspatercept: a treatment for ineffective erythropoiesis in thalassemia
Khaled M. Musallam, Ali T. Taher
Hematology (2024) Vol. 2024, Iss. 1, pp. 419-425
Closed Access
Page 1

Scroll to top